Post-approval studies (Phase 4)Study completedNCT00331435What this trial is testingPDT Study for Exudative AMD With PCVWho this might be right forAge Related Macular Degeneration Ophthalmic PDT Study Group 113
Post-approval studies (Phase 4)Looking for participantsNCT06709339What this trial is testingStudy to Investigate the Efficacy, Safety and Durability of Faricimab in Caucasian Patients With Polypoidal Choroidal Vasculopathy (MONDEGO)Who this might be right forPolypoidal Choroidal Vasculopathy Association for Innovation and Biomedical Research on Light and Image 120
Testing effectiveness (Phase 2)Study completedNCT01023295What this trial is testingStudy Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)Who this might be right forPolypoidal Choroidal Vasculopathy Mateon Therapeutics 20
Not applicableUnknownNCT00383812What this trial is testingIntravitreal Bevacizumab for Polypoidal Choroidal VasculopathyWho this might be right forPolypoidal Choroidal Vasculopathy Asan Medical Center 20
Not applicableStudy completedNCT03459144What this trial is testingComparison of PDT, Intravitreal Ranibizumab and Combination for Polypoidal Choroidal Vasculopathy Under 1+PRN RegimenWho this might be right forPolypoidal Choroidal Vasculopathy Sun Yat-sen University 60
Not applicableStudy completedNCT04075188What this trial is testingTreatment of Polypoidal Choroidal Vasculopathy in PachychoroidWho this might be right forChoroidal NeovascularizationChoroid Disease Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo 17
Not applicableEnded earlyNCT02857894What this trial is testingGenetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)Who this might be right forChoroidal Neovascularization Fondation Ophtalmologique Adolphe de Rothschild 7
Large-scale testing (Phase 3)Study completedNCT05666804What this trial is testingStudy Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal VasculopathyWho this might be right forMacular Polypoidal Choroidal Vasculopathy (PCV) Novartis Pharmaceuticals 148
Post-approval studies (Phase 4)Study completedNCT02495181What this trial is testingRandomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal VasculopathyWho this might be right forPolypoidal Choroidal Vasculopathy Association for Innovation and Biomedical Research on Light and Image 50
Not applicableStudy completedNCT02381730What this trial is testingAssessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept TreatmentWho this might be right forPolypoidal Choroidal Vasculopathy Fondation Ophtalmologique Adolphe de Rothschild 37
Not applicableLooking for participantsNCT02141308What this trial is testingOCT in Rare Chorioretinal DiseasesWho this might be right forRetinal Artery OcclusionsPolypoidal Choroidal VasculopathyRetinal Arterial Macroaneurysm+2 more Oregon Health and Science University 150
Not applicableUnknownNCT05639660What this trial is testingClinical Implication of Aflibercept in PCV Treatment in ChinaWho this might be right forPolypoidal Choroidal Vasculopathy Peking Union Medical College Hospital 1,000
Post-approval studies (Phase 4)Study completedNCT02860858What this trial is testingIntravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)Who this might be right forSymtomatic Macular Polypoidal Choroidal Vasculopathy Department of Medical Services Ministry of Public Health of Thailand 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT07365371What this trial is testingA Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)Who this might be right forPolypoidal Choroidal Vasculopathy (PCV)Neovascular Age Related Macular Degeneration (AMD) Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 174
Post-approval studies (Phase 4)UnknownNCT02092532What this trial is testingIntravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial)Who this might be right forNeovascular Polypoidal Choroidal Vasculopathy Southeast Retina Center, Georgia 20
Early research (Phase 1)Ended earlyNCT01334255What this trial is testingISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)Who this might be right forPigment Epithelial Detachment Lpath, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT00470977What this trial is testingTreatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related MaculopathyWho this might be right forCoats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more Manhattan Eye, Ear & Throat Hospital 18
Not applicableUnknownNCT04707027What this trial is testingInterval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving AfliberceptWho this might be right forPolypoidal Choroidal Vasculopathy Chiang Mai University 80
Post-approval studies (Phase 4)Study completedNCT00674323What this trial is testingEfficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal VasculopathyWho this might be right forPolypoidal Choroidal Vasculopathy Novartis 61
Not applicableStudy completedNCT03929731What this trial is testingLong-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)Who this might be right forPolypoidal Choroidal Vasculopathy Singapore National Eye Centre 72